Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
HLA complex group 25 (non-protein-coding) (HCG25)
- Target
- HCG25
- Molecular classification
- Other (non-coding RNA)
01
Overview
HLA complex group 25 (HCG25) is classified as a non-coding RNA gene located on human chromosome 6 within the major histocompatibility complex (MHC, also called the HLA complex)[3][6][8]. Unlike protein-coding HLA genes (such as HLA-A25), HCG25 does not encode a cell surface protein and its precise biological function remains unclear. There are no known roles in antigen presentation or disease association, and it is not recognized as a target for therapeutics or drug interactions[3][6]. It is often listed among non-coding RNA elements annotated within the HLA region in genomic databases, but its biological impact requires further research. Note: It is important not to confuse HCG25 (non-coding RNA) with HLA-A*25 or HLA-A25, which are classical MHC class I antigens critical in immune response and transplantation medicine[1][5][6].
- Other names
- dJ1033B10.16hypothetical protein LOC105370606HCG25 (non-protein-coding)
02
Mechanism of action
None applicable
03
Biological functions
Unknown
04
Disease associations
Unknown
Beyond the preview
Go deeper on HLA complex group 25 (non-protein-coding) (HCG25).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on HLA complex group 25 (non-protein-coding) (HCG25).